India to Canada: Clindamycin Export Trade Route
India has recorded 63 verified shipments of Clindamycin exported to Canada, representing a combined trade value of $2.1M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $33.6K USD. The leading Indian exporter is AUROBINDO PHARMA LTD , which accounts for 44% of total export value with 17 shipments worth $927.5K USD. On the buying side, AURO PHARMA INC is the largest importer in Canada with $735.0K USD in purchases. The top 3 suppliers — AUROBINDO PHARMA LTD , AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Canada Clindamycin corridor is one of India's established pharmaceutical export routes, with 63 shipments documented worth a combined $2.1M USD. The route is dominated by AUROBINDO PHARMA LTD , which alone accounts for roughly 44% of all export value, reflecting the consolidated nature of India's clindamycin manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $33.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with clindamycin's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 23.6%, placing it at rank #17 among India's top clindamycin export destinations globally.
On the import side, key buyers of Indian clindamycin in Canada include AURO PHARMA INC, AURO PHARMA INC, , AURO PHARMA INC and 5 others. AURO PHARMA INC is the single largest importer with 29 shipments valued at $735.0K USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ3
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#17
- Annual growth+23.6%
- Demand growth+20.0%
- Regulatory ease87/100
Top 10 Indian Clindamycin Exporters to Canada
Showing top 10 of 4 Indian suppliers exporting Clindamycin to Canada, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD Avg $54.6K per shipment | 17 | $927.5K | 43.8% |
| 2 | AUROBINDO PHARMA LTD Avg $18.4K per shipment | 34 | $626.0K | 29.5% |
| 3 | AUROBINDO PHARMA LIMITED Avg $51.4K per shipment | 11 | $565.2K | 26.7% |
| 4 | MEDREICH LIMITED Avg $0 per shipment | 1 | $0 | 0.0% |
This table shows the top 10 of 4 Indian companies exporting clindamycin to Canada, ranked by total trade value. The listed exporters are: AUROBINDO PHARMA LTD , AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MEDREICH LIMITED . AUROBINDO PHARMA LTD is the dominant supplier with 17 shipments worth $927.5K USD, giving it a 44% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Clindamycin Importers in Canada
Showing top 10 of 8 known buyers in Canada receiving Clindamycin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian clindamycin in Canada include AURO PHARMA INC, AURO PHARMA INC, , AURO PHARMA INC , AURO PHARMA INC NA, AURO PHARMA INC,, among 8 total buyers. The largest importer is AURO PHARMA INC, accounting for $735.0K USD across 29 shipments — representing 35% of all clindamycin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AURO PHARMA INC | 29 | $735.0K | 34.7% |
| 2 | AURO PHARMA INC, | 8 | $450.3K | 21.3% |
| 3 | AURO PHARMA INC | 8 | $407.0K | 19.2% |
| 4 | AURO PHARMA INC NA | 2 | $201.3K | 9.5% |
| 5 | AURO PHARMA INC, | 7 | $152.5K | 7.2% |
| 6 | AURO PHARMA INC, C/O LYNDEN, | 7 | $102.4K | 4.8% |
| 7 | AURO PHARMA INC, C/O | 1 | $70.1K | 3.3% |
| 8 | ALTASCIENCE COMPANY INC | 1 | $0 | 0.0% |
Top 10 Clindamycin Formulations Imported by Canada
Showing top 10 of 25 product formulations shipped on the India to Canada Clindamycin route, ranked by trade value
Canada imports a wide range of clindamycin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG — accounts for $937.7K USD across 16 shipments. There are 25 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG | 16 | $937.7K | 44.3% |
| 2 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG | 2 | $201.3K | 9.5% |
| 3 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 150MG | 3 | $151.2K | 7.1% |
| 4 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG(AURO-CLINDAMYCIN 300)100'S | 9 | $149.9K | 7.1% |
| 5 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG USP CLINDAMYCIN 100'S 11280 PACK | 1 | $104.0K | 4.9% |
| 6 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG (CLINDAMYCIN) 100'S (11256 PACK) | 1 | $96.9K | 4.6% |
| 7 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG(AURO-CLINDAMYCIN 300) 100'S (QTY: 7584PAK) | 1 | $59.0K | 2.8% |
| 8 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MGAURO-CLINDAMYCIN 300 100'S QTY: 5631PAK | 1 | $53.4K | 2.5% |
| 9 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG (USP) (CLINDAMYCIN) 100'S (4488 PACK) | 1 | $41.4K | 2.0% |
| 10 | CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG (USP) (CLINDAMYCIN) 100'S (4704 PACK) | 1 | $38.8K | 1.8% |
Showing top 10 of 25 Clindamycin formulations imported by Canada on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 15 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's clindamycin exports to Canada are driven primarily by a handful of large-scale manufacturers. AUROBINDO PHARMA LTD with 17 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AUROBINDO PHARMA LTD , AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $33.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as clindamycin hydrochloride capsules 300mg and clindamycin hydrochloride capsules 150mg , suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AURO PHARMA INC is the largest importer with 29 shipments worth $735.0K USD — representing 35% of all clindamycin imports from India on this route. A total of 8 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.1M
- Avg. Shipment
- $33.6K
- Suppliers
- 4
- Buyers
- 8
- Transit (Sea)
- ~20 days
- Annual Growth
- +23.6%
Related Analysis
Reverse Direction
Canada → India — Clindamycin (Import)Other Clindamycin Routes
Unlock the Full India to Canada Clindamycin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 63 shipments on this route.
Frequently Asked Questions — India to Canada Clindamycin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Clindamycin to Canada?
The leading Indian exporters of Clindamycin to Canada are AUROBINDO PHARMA LTD , AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED. AUROBINDO PHARMA LTD holds the largest market share at approximately 44% of total trade value on this route.
Q What is the total value of Clindamycin exports from India to Canada?
India exports Clindamycin to Canada worth approximately $2.1M USD across 63 recorded shipments. The average value per shipment is $33.6K USD.
Q Which ports does India use to ship Clindamycin to Canada?
The most active port of origin is HYDERABAD AIR with 15 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 28% by air.
Q How long does shipping take from India to Canada for Clindamycin?
The average transit time for Clindamycin shipments from India to Canada is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Canada Clindamycin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 23.6% with demand growth tracking at 20.0%. The route is ranked #17 among India's top Clindamycin export destinations globally.
Q How many suppliers are active on the India to Canada Clindamycin route?
There are currently 4 active Indian suppliers exporting Clindamycin to Canada. The market is moderately concentrated with AUROBINDO PHARMA LTD accounting for 44% of total shipment value.
Q Who are the main importers of Clindamycin from India in Canada?
The leading importers of Indian Clindamycin in Canada include AURO PHARMA INC, AURO PHARMA INC, , AURO PHARMA INC , AURO PHARMA INC NA, AURO PHARMA INC,. AURO PHARMA INC is the largest buyer with 29 shipments worth $735.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Canada export trade corridor identified from Indian Customs (DGFT) records for Clindamycin.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 8 importers in Canada matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 63 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
63 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists